West Pharmaceutical Services Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.8% | +4.9% | -2.3% | -30.0% | -32.7% | +64.8% | +28.4% | -0.4% | +24.2% | +68.0% | -10.2% | +4.5% | +2.0% | +0.4% | -5.5% | +43.4% | +17.7% | -17.1% | +16.1% | +3.3% | +20.0% | +9.6% | +27.2% | +28.7% | +23.6% | +24.0% | +7.3% | -15.9% | +15.5% | |
| – | +3.9% | +1.3% | +10.5% | +3.6% | -13.5% | +3.1% | +0.0% | +0.6% | +42.8% | +11.2% | +7.4% | +7.1% | +12.4% | +7.5% | +3.4% | +1.6% | +10.8% | +5.6% | -0.1% | +0.9% | +6.6% | +8.0% | -1.0% | +5.5% | +12.1% | -1.4% | +13.8% | +13.2% | +8.5% | |
| – | -1,850.0% | – | – | – | – | – | – | – | – | – | +1,211.1% | -45.8% | +17.2% | +4.0% | +7.7% | +84.5% | +36.8% | -12.3% | +59.1% | -34.1% | -17.4% | -6.2% | +61.6% | +39.3% | +10.3% | -36.8% | -1.7% | -19.7% | +27.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -26.1% | +549.0% | -19.3% | -113.5% | – | -50.7% | +93.6% | -81.3% | +213.4% | -36.2% | -182.8% | – | – | – | – | |
| – | – | -110.7% | – | – | -408.2% | – | – | -85.0% | -1,173.7% | – | – | – | – | – | -803.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | +2,651.7% | |
| – | +8.5% | +123.0% | -17.3% | -9.6% | -23.0% | -14.5% | +61.3% | -5.6% | -5.7% | +66.9% | +43.3% | +7.5% | -22.5% | -31.5% | +31.2% | +36.4% | +18.0% | -28.0% | +17.4% | +29.3% | -23.1% | -20.0% | +20.7% | +38.0% | +45.3% | +12.3% | +27.2% | +4.1% | -24.2% | |
| – | +34.7% | +123.6% | -16.4% | -1.9% | -74.5% | +109.7% | +76.8% | -57.1% | +828.2% | -60.5% | +73.4% | -17.8% | -4.9% | -39.3% | +62.8% | -3.7% | +29.2% | -30.6% | +24.5% | +35.8% | -24.0% | -24.6% | +126.2% | -21.3% | +41.0% | +13.9% | +27.9% | +2.7% | -24.5% | |
| – | -6.0% | +0.0% | +9.6% | -4.9% | +7.1% | +5.7% | +6.3% | +8.5% | +10.2% | +12.8% | +10.1% | +6.3% | +8.1% | +8.0% | +6.9% | +7.3% | +7.6% | +8.6% | +11.3% | +10.5% | +9.2% | +7.7% | +7.1% | +6.7% | +6.2% | +5.9% | +5.4% | +3.7% | +3.6% | |
| – | – | – | -70.0% | -40.3% | -99.1% | +0.0% | – | – | +0.0% | – | – | -87.9% | -75.0% | +61.5% | +66.7% | +34.3% | +10.6% | -21.2% | +36.6% | +898.2% | +33.1% | -4.8% | +17.4% | +39.0% | +31.5% | +46.3% | +103.1% | +25.6% | -76.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -54.4% | – | -153.8% | +298.2% | +22.9% | +154.7% | -50.0% | -99.7% | – | -103.8% | -4.3% | +1,968.2% | -94.7% | +1,050.0% | -96.0% | |
| – | -75.4% | +167.6% | – | +30.2% | -241.1% | +108.9% | -63.3% | +27.3% | – | -150.0% | – | -124.7% | +8.1% | +50.4% | -27.4% | -86.2% | +50.0% | +503.9% | +34.7% | +174.5% | -4.3% | -26.0% | -54.4% | +272.6% | +22.6% | +74.7% | +56.5% | +35.5% | -70.3% | |
| – | +152.5% | -184.0% | – | -118.6% | – | – | – | +573.9% | -164.5% | – | – | -134.6% | – | – | -167.9% | – | -2.9% | -62.8% | -23.7% | -471.0% | – | +208.5% | +0.2% | +73.5% | -16.6% | -10.5% | -130.7% | – | – | |
| – | +5.0% | -117.1% | – | -245.0% | – | – | -48.1% | +36.9% | +173.9% | +69.8% | -100.4% | – | – | +115.7% | -47.4% | +63.4% | +16.8% | +9.4% | +14.1% | -39.1% | +169.3% | +38.8% | +30.9% | +23.8% | +10.9% | +32.9% | -5.7% | -33.3% | +69.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.